XML 57 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-based compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation by Line Item in Consolidated Statements of Income The following tables present the detail of share-based compensation expense by line item in the consolidated statements of income as well as by award type, for the years ended December 31, 2023, 2022, and 2021:

 

 

Year Ended December 31,

 

(U.S. Dollars, in thousands)

 

2023

 

 

2022

 

 

2021

 

Cost of sales

 

$

1,901

 

 

$

826

 

 

$

779

 

Sales and marketing

 

 

8,174

 

 

 

3,865

 

 

 

3,385

 

General and administrative

 

 

21,743

 

 

 

12,917

 

 

 

10,289

 

Research and development

 

 

3,889

 

 

 

835

 

 

 

979

 

Total

 

$

35,707

 

 

$

18,443

 

 

$

15,432

 

 

 

 

Year Ended December 31,

 

(U.S. Dollars, in thousands)

 

2023

 

 

2022

 

 

2021

 

Stock options

 

$

6,130

 

 

$

1,114

 

 

$

1,893

 

Time-based restricted stock awards and stock units

 

 

27,290

 

 

 

9,452

 

 

 

7,437

 

Performance-based / Market-based restricted stock units

 

 

227

 

 

 

6,425

 

 

 

4,414

 

Stock purchase plan

 

 

2,060

 

 

 

1,452

 

 

 

1,688

 

Total

 

$

35,707

 

 

$

18,443

 

 

$

15,432

 

Schedule of Assumptions Used in Determining Fair Value of Stock Options

The fair value of time-based stock options is determined using the Black-Scholes valuation model, with such value recognized as expense over the service period, which is typically three to four years, net of actual forfeitures. A summary of the Company’s assumptions used in determining the fair value of the stock options granted during each of the years ended December 31, 2023, 2022, and 2021, is shown in the following table. The Company did not grant any time-based stock options in 2022.

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Assumptions:

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

6.0

 

 

 

 

 

6.0

 

Expected volatility

 

36.8% – 42.3%

 

 

 

 

 

34.4% – 34.8%

 

Risk free interest rate

 

3.38% – 4.61%

 

 

 

 

 

0.83% – 1.25%

 

Dividend yield

 

 

 

 

 

 

 

 

 

Weighted average grant date fair value

 

$

8.43

 

 

$

 

 

$

12.33

 

Schedule of Stock Option Plans

Summaries of the status of the Company’s stock option plans as of December 31, 2023, and 2022, and changes during the year ended December 31, 2023, are presented below:

(In thousands)

 

Options

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual
Term (Years)

 

Outstanding at December 31, 2022

 

 

1,299

 

 

$

39.29

 

 

 

 

Assumed SeaSpine awards

 

 

1,890

 

 

$

36.05

 

 

 

 

Granted

 

 

1,837

 

 

$

19.92

 

 

 

 

Exercised

 

 

-

 

 

$

-

 

 

 

 

Forfeited or expired

 

 

(1,803

)

 

$

31.62

 

 

 

 

Outstanding at December 31, 2023

 

 

3,223

 

 

$

30.64

 

 

 

4.97

 

Vested and expected to vest at December 31, 2023

 

 

3,223

 

 

$

30.64

 

 

 

4.97

 

Exercisable at December 31, 2023

 

 

1,828

 

 

$

36.78

 

 

 

2.68

 

Schedule of Changes in Time-Based and Market-Based Restricted Stock Awards and Stock Units

A summary of the status of our time-based and performance-based and/or market-based restricted stock units as of December 31, 2023, and 2022, and changes during the year ended December 31, 2023, are presented below:

 

 

 

Time-based Restricted Stock
Awards and Stock Units

 

 

Performance-based and/or Market-based
Restricted Stock Units

 

(In thousands)

 

Shares

 

 

Weighted
Average Grant
Date Fair Value

 

 

Shares

 

 

Weighted
Average Grant
Date Fair Value

 

Outstanding at December 31, 2022

 

 

847

 

 

$

34.18

 

 

 

516

 

 

$

40.29

 

Assumed SeaSpine awards

 

 

490

 

 

$

22.76

 

 

 

 

 

$

 

Conversion of performance-based and market-based stock units to time-based stock units

 

 

516

 

 

$

40.29

 

 

 

(516

)

 

$

40.29

 

Granted

 

 

1,496

 

 

$

18.51

 

 

 

13

 

 

$

20.10

 

Vested and settled

 

 

(749

)

 

$

29.04

 

 

 

(4

)

 

$

22.76

 

Cancelled

 

 

(560

)

 

$

21.12

 

 

 

 

 

$

 

Outstanding at December 31, 2023

 

 

2,040

 

 

$

26.96

 

 

 

9

 

 

$

22.69